A detailed history of Invesco Ltd. transactions in Opti Nose, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 42,677 shares of OPTN stock, worth $17,924. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,677
Previous 36,074 18.3%
Holding current value
$17,924
Previous $37,000 24.32%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.67 - $1.27 $4,424 - $8,385
6,603 Added 18.3%
42,677 $28,000
Q2 2024

Aug 13, 2024

BUY
$0.82 - $1.44 $3,261 - $5,726
3,977 Added 12.39%
36,074 $37,000
Q1 2024

May 14, 2024

SELL
$1.17 - $1.94 $320 - $531
-274 Reduced 0.85%
32,097 $46,000
Q4 2023

Feb 12, 2024

SELL
$1.02 - $1.47 $6,885 - $9,922
-6,750 Reduced 17.25%
32,371 $41,000
Q3 2023

Nov 13, 2023

BUY
$0.93 - $1.38 $69 - $103
75 Added 0.19%
39,121 $48,000
Q2 2023

Aug 11, 2023

BUY
$1.11 - $2.05 $43,341 - $80,044
39,046 New
39,046 $48,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $35M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.